Conversely, no differences were detected between MEN1611- and vehicle-treated nodules in the proliferative rate of tumor stem cells, measured as percentage ratio between CD15+Ki67+ cells and total number of CD15+ cells (p = 0.7346; Student’s t-test; Figures 8C, D). This evidence concerns the gene MKI67 and neoplasm.